Science TLDR

Reference PMID: 38723627 This episode explores groundbreaking research demonstrating that the efficacy of cancer immunotherapy is influenced by the time of day of administration, highlighting the critical role of circadian rhythms in shaping anti-tumor immune responses. Key Findings: The number of tumor-infiltrating leukocytes (TILs) in melanoma tumors oscillates throughout the day, peaking in the...

This episode delves into a fascinating study that uncovers a novel immune checkpoint molecule, ITPRIPL1, and its role in suppressing T cell activation and enabling tumor immune evasion. Key Findings: ITPRIPL1, a protein normally enriched in the testes, is overexpressed in various human cancers, particularly those with low or no PD-L1 expression. ITPRIPL1 directly binds to CD3ε, a component of the...

This episode explores a groundbreaking study that unveils the remarkable diversity and potential of neutrophils in cancer immunotherapy. Key Findings: Researchers identified 10 distinct neutrophil states within the tumor microenvironment, including an antigen-presenting state characterized by HLA-DR expression. HLA-DR+ neutrophils can effectively present tumor neoantigens and activate T cell respo...

This episode dives into a promising study utilizing immunoinformatics to design a novel vaccine against Renal Cell Carcinoma (RCC), a prevalent and deadly form of kidney cancer. Key Findings: Researchers identified multiple immunogenic epitopes within the CD70 protein, a molecule overexpressed in RCC. These epitopes were carefully selected based on their antigenicity, non-allergenicity, and non-to...

Main Topic: A critical evaluation of AF-cluster, a method used to predict the structures of metamorphic proteins with AlphaFold2 (AF2). Key Points: Metamorphic proteins can adopt multiple stable conformations, making their structure prediction challenging. AF-cluster, initially presented as a solution, is called into question by Schafer et al. due to: Inaccurate predictions compared to random samp...